Ignite Creation Date:
2025-12-24 @ 12:17 PM
Ignite Modification Date:
2025-12-28 @ 10:52 AM
Study NCT ID:
NCT00270361
Status:
COMPLETED
Last Update Posted:
2011-07-26
First Post:
2005-12-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.
Sponsor:
Scios, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-12
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-22
First Submit QC Date:
None
Study First Post Date:
2005-12-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-07-25
Last Update Post Date:
2011-07-26
Last Update Post Date Type:
ESTIMATED